| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/12/2008 | US7329405 Can be produced in a transfectoma or in a non-human transgenic animal capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching |
| 02/12/2008 | US7329353 LC/MS method of analyzing high molecular weight proteins |
| 02/12/2008 | CA2387018C Chemokine receptor |
| 02/12/2008 | CA2268397C Magnetically activated cell sorting for production of proteins |
| 02/12/2008 | CA2234716C Peptides for treatment of inflammation and shock |
| 02/12/2008 | CA2203246C Alk-7 (activin like kinase), a serine threonine kinase receptor |
| 02/07/2008 | WO2008016186A1 Antibody specific to intact human autotaxin, method of screening the same and method and reagent for examining malignant lymphoma by assaying autotaxin |
| 02/07/2008 | WO2008016134A1 Method for predicting prognosis of rheumatoid arthritis patients |
| 02/07/2008 | WO2008015218A2 Method for diagnosis of a disease involving an anti-at1-receptor antibody |
| 02/07/2008 | WO2008014603A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/07/2008 | WO2008014583A1 Cancerous disease modifying antibodies |
| 02/07/2008 | WO2007135546A3 TREATMENT OF CANCER WITH ANTI-IL-1α ANTIBODIES |
| 02/07/2008 | WO2007134350A8 Antibodies specific for bet v 1 and use thereof in the prevention and treatment of bet v 1-induced diseases |
| 02/07/2008 | WO2007127317A3 Humanized c-kit antibody |
| 02/07/2008 | WO2007113685A3 USE OF THE α CHAIN OF BRAIN SPECTRIN AND FRAGMENTS THEREOF, FOR DIAGNOSING CEREBRAL DISEASES |
| 02/07/2008 | WO2007059360A3 Oral use of specific antibodies for intestinal health |
| 02/07/2008 | US20080033157 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
| 02/07/2008 | US20080033150 Monoclonal antibodies; hybridomas; malondialdehyde-modified (MDA); atherosclerosis |
| 02/07/2008 | US20080033149 Human anti-TNF antibodies and peptides |
| 02/07/2008 | US20080033148 Anti-il-tif antibodies and methods of using in inflammation |
| 02/07/2008 | US20080032928 Treatment of mucus hypersecretion |
| 02/07/2008 | US20080032926 Knockout Non-Human Animal |
| 02/07/2008 | US20080032924 Antifungal Peptides |
| 02/07/2008 | US20080032402 enriching luminal restricted colony forming cells in a sample containing mammary gland cells ; use of the cell preparations in the study of cell biology and cancer |
| 02/07/2008 | US20080032386 Stabilized Proline Transporter |
| 02/07/2008 | US20080032379 Pyrenyloxysulfonic acid flurescent agents |
| 02/07/2008 | US20080032378 have increased activity and stability at acidic, neutral and alkaline pH and increased temperature; for producing an alcohol, high-maltose or high-glucose syrup or a mixed syrup, and for liquifying a starch-comprising composition |
| 02/07/2008 | US20080032336 Chemokine receptor materials and methods |
| 02/07/2008 | US20080032335 Provides polypeptide having wide substrate specificity and having omega 3 fatty acid desaturation activity, which makes efficiently unsaturated bond at omega 3 position, and a polynucleotide coding for the same; by expressing the polypeptide in the organism, mass production of n-3 series PUFAs is enabled |
| 02/07/2008 | US20080032332 Wound healing agents; anticancer agents; cardiovascular disorders |
| 02/07/2008 | US20080032304 FULL-LENGTH cDNA AND POLYPEPTIDES |
| 02/07/2008 | US20080032299 Methods for prognosis and treatment of solid tumors |
| 02/07/2008 | US20080032289 Novel TWIK-6, TWIK-7, IC23927, TWIK-8, IC47611, IC47615, HNMDA-1, TWIK-9, alpha2delta-4, 8099, 46455, 54414, 53763, 97076, 97102, 44181, 67084Fl and 67084alt molecules and uses therefor |
| 02/07/2008 | US20080031969 antiinflammatory mixture for the treatment of psoriasis; with proteins comprising beta -lactoglobulin and alpha -lactalbumin, and insulin-like growth factors; autoimmune inflammatory disorders |
| 02/07/2008 | US20080031888 Tumor antigens |
| 02/07/2008 | US20080031885 Use of Goat Serum for Veterinary Treatment |
| 02/07/2008 | US20080031881 Medicament for treating cancer |
| 02/07/2008 | US20080031880 Use of ErbB receptor ligands in treating diabetes |
| 02/07/2008 | US20080031879 Wound healing agents; antiscarring; regeneration: antifibrotic agents: treatment of keloids or hypertrophic scars |
| 02/07/2008 | US20080031877 Purification of bacterial antigens |
| 02/07/2008 | US20080031876 Use preventing transplant rejection, treating autoimmune diseases, and in leukocyte typing and FAC sorting; CD28/CTLA4Ig fusion proteins |
| 02/07/2008 | US20080031875 Treatment method |
| 02/07/2008 | US20080031871 Memory and learning impairments associated with disruption of Ephrin receptor A6 (EphA6) gene |
| 02/07/2008 | US20080031818 Use of Modulators of a Novel Form of Muscle Selective Calcineurin Interacting Protein (Mcip-1-38) as a Treatment for Cardiovascular Diseases |
| 02/07/2008 | CA2658504A1 Cancerous disease modifying antibodies |
| 02/06/2008 | EP1884775A1 Method for diagnosis of a disease involving an anti-AT1-receptor antibody |
| 02/06/2008 | EP1884524A2 Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 02/06/2008 | EP1884523A1 Biomarkers for polo-like kinase 1 activity |
| 02/06/2008 | EP1884522A1 Antibody binding to a polo-like kinase 1 phosphorylation site of the human cohesin Wapl |
| 02/06/2008 | EP1883698A1 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen |
| 02/06/2008 | EP1883653A2 Recombinant method for the production of a monoclonal antibody to cd52 for the treatment of chronic lymphocytic leukemia |
| 02/06/2008 | EP1883422A2 Tcr-independent activation of t cells |
| 02/06/2008 | EP1883410A2 Antibody or antibody fragment coupled with an immunogenic agent |
| 02/06/2008 | EP1402036B1 Expression vectors encoding bacteriophage signal peptides |
| 02/06/2008 | EP1292619B1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/06/2008 | EP1021728B1 Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins |
| 02/06/2008 | EP0678524B1 Anti-human soluble fibrin antibodies, hybridoma producing them, and immunoassaying method |
| 02/06/2008 | CN101120087A Anti-il-12 antibodies, epitopes, compositions, methods and uses |
| 02/06/2008 | CN101120022A Methods for treating autoimmune disorders |
| 02/06/2008 | CN101120021A Polypeptides that bind br3 and uses thereof |
| 02/06/2008 | CN101120020A Antiangiogenesis therapy of autoimmune disease in patients who have failed prior therapy |
| 02/06/2008 | CN101120019A Antibody specifically reacting with ages derived from 3,4-dge |
| 02/06/2008 | CN101120018A Human monoclonal antibody specific for lipopolysaccharides (LPS) of the pseudomonas aeruginosa IATS O11 serotype |
| 02/06/2008 | CN101120017A Affinity-plus ion exchange-chromatography for purifying antibodies |
| 02/06/2008 | CN101120016A Adamts-7 as a biomarker for cancers of epithelial origin |
| 02/06/2008 | CN101120015A Interleukin-15 antagonist peptide |
| 02/06/2008 | CN101120014A Modulation of ovulation |
| 02/06/2008 | CN101119746A Agent for stimulating the production of a blood coagulation factor VIII |
| 02/06/2008 | CN100366637C Human interleukin 8 antagonist protein and preparation method thereof |
| 02/06/2008 | CN100366631C IgG Fc/HIV-gp120/C3d fusion protein |
| 02/06/2008 | CN100366293C Inhibitors of complement activation |
| 02/05/2008 | US7326774 Monoclonal antibody and nematode larval antigens |
| 02/05/2008 | US7326773 PRO6493 antibodies |
| 02/05/2008 | US7326768 Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders |
| 02/05/2008 | US7326682 Conotoxin peptides |
| 02/05/2008 | US7326569 Hybridoma cell lines producing chimeric antibody having the variable regions of the antibody produced by a cell line with ATCC (TM) deposit number HB11364, HB11637, or HB11363 |
| 02/05/2008 | US7326567 Plasmid system for multigene expression |
| 02/05/2008 | US7326551 Nucleotide sequences coding polypeptide for use in generation of bacteria which generate synthetic fuels |
| 02/05/2008 | US7326545 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/05/2008 | US7326543 Gene encoding protein from merozoite of Babesia caballi, recombinant protein obtained with said gene and use thereof |
| 02/05/2008 | US7326541 Fragments and variants of Staphylococcus aureus DNAG primase, and uses thereof |
| 02/05/2008 | US7326537 In human blood, urine, saliva, tissue biopsy or autopsy material; immunoassay using a mono- or polyclonal antibody; detecting overexpression; diagnosis |
| 02/05/2008 | US7326535 Using a for diagnosis, therapy |
| 02/05/2008 | US7326530 Method for localizing polypeptide on cell surface |
| 02/05/2008 | US7326529 Using cancer specific genes |
| 02/05/2008 | US7326415 derived from epithelial cells and malignant lymphoma; also for irritable bowel syndrome, viral and other infections; genetic engineering; kits |
| 02/05/2008 | US7326414 Monoclonal antibody that specifically binds macrophage colony stimulating factor; rheumatoid arthritis |
| 02/05/2008 | US7326413 Antibodies against the PRO1434 polypeptide |
| 02/05/2008 | US7326402 Method of diagnosing, monitoring, staging, imaging and treating cancer |
| 02/05/2008 | CA2348240C Transcriptional activator lec1 nucleic acids, polypeptides and their uses |
| 02/05/2008 | CA2187161C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase ii (icerel-ii) |
| 02/05/2008 | CA2124953C Peptides related to prion proteins |
| 02/01/2008 | WO2007012188A1 GLP/1/EXENDM 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES |
| 02/01/2008 | CA2658673A1 Composition and method for prevention and treatment of type i and type ii diabetes |
| 01/31/2008 | WO2008014240A2 Dimeric iap inhibitors |
| 01/31/2008 | WO2008013953A2 Tyrosine phosphorylation sites |
| 01/31/2008 | WO2008013935A2 Tyrosine phosphorylation sites |
| 01/31/2008 | WO2008013934A2 Tyrosine phosphorylation sites |
| 01/31/2008 | WO2008013552A2 Fully human hybridoma fusion partner cell lines |
| 01/31/2008 | WO2008013455A1 Means and methods for preventing elevated blood glucose levels in humans with animal antibodies produced in milk |